… Dabigatran 150 mg (twice daily) was cost-effective in atrial fibrillation populations at high
risk of … Warfarin was cost-effective in moderate-risk atrial fibrillation populations unless …

… In this paper, a recently published cost-effectiveness analysis comparing rhythm-control …
atrial fibrillation is used to illustrate the CEAC [12]. After a brief introduction on cost-effectiveness …

… 93 The proportion of atrial fibrillation that is asymptomatic (by atrial fibrillation type) 93
Disease progression from paroxysmal atrial fibrillation to persistent/permanent atrial fibrillation …

… cost-effectiveness comparison between 2 of the 4 therapies for stroke prevention in patients
in the United States with atrial fibrillation… the long-term cost-effectiveness of stroke prevention …

… in our cost effectiveness analysis for outcomes including stroke, major bleeding, and all-cause
mortality are also comparable to those observed in recent prospective atrial fibrillation …

Objective: To assess the cost-effectiveness of radiofrequency catheter ablation (RFCA)
compared with anti-arrhythmic drug (AAD) therapy for the treatment of atrial fibrillation (AF) from …

… approach in patients with atrial fibrillation (AF) compared with usual care. The aim of the
present study is to assess cost-effectiveness of this nurse-led care programme vs. usual care. …

… cost-effectiveness plane … costs per patient and benefits per patient of atrial fibrillation
screening compared with no screening. Atrial fibrillation screening was found to be cost-effective if …

… Atrial fibrillation (AF) imposes a substantial cost burden on the healthcare system. Weight …
) clinic is cost-effective. In this study, we aim to evaluate the cost and clinical effectiveness of a …

… fibrillation in the remaining 66% of patients. … : Atrial fibrillation was likely to be recurrent,
atrial fibrillation was likely to cause morbidity or death, long-term treatment for atrial fibrillation …